Patent · US Expired

Purification of red blood cells by separation and diafiltration

US7001715B2 · kind B2 · utility

7Cited by
29References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 28, 2002
Grant dateFeb 21, 2006
Priority date
Expiry dateApr 8, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K35/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Red blood cells are purified by separating whole blood, such as by centrifugation, to form a red blood cell fraction and a liquid fraction. The whole blood can be defibrinated or treated to prevent coagulation prior to separation. Preferably, the whole blood is bovine blood. The red blood cell fraction is then diafiltered to purify the red blood cells. The purified red blood cells can then be lysed to form a lysate of purified red blood cells. The purified red blood cells and the lysate of purified red blood cells are suitable for use in producing hemoglobin blood substitute.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.